Insider Transactions in Q3 2025 at Myriad Genetics Inc (MYGN)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 03
2025
|
Jennifer Lynne Fox Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,435
-3.55%
|
$26,610
$6.8 P/Share
|
|
Aug 16
2025
|
Benjamin Richard Wheeler Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+38.66%
|
-
|